Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society

A BSTRACT Background: Medication-related osteonecrosis of the jaw (MRONJ) is an intense negative drug response causing increasing bone destruction in the maxillofacial area of patients. Aims and Objectives: To evaluate the knowledge and attitude of dental practitioner regarding risk factors of MRONJ in Saudi Arabia. Materials and Methods: A cross-sectional, questionnaire survey was carried out in King Khalid Hospital, Al-Kharj among dental practioners. Results: Approximately 60% of the practioners had a poor knowledge and there was a weak positive correlation with work experience. Conclusion: Poor knowledge regarding the MRONJ invites a continuing dental education specially to focus on general practioners.

show abstract

“…[ 14 ] Other study showed that oral maxillofacial surgeons have more knowledge compared to general dentists. [ 15 ]…”

Section: Discussionmentioning

confidence: 99%

Knowledge, attitude, and management of general dentist toward medication-related osteonecrosis of the jaws

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Oral and maxillofacial surgeons in Iraq had better awareness of the risk of MRONJ than physicians and GDPs. 29 …”

Section: Discussionmentioning

confidence: 99%

“…Oral and maxillofacial surgeons in Iraq had better awareness of the risk of MRONJ than physicians and GDPs. 29 Although osteonecrosis of the jaw may develop spontaneously in a small proportion of patients using antiresorptive and antiangiogenic medication, most affected patients develop osteonecrosis following dentoalveolar surgery. 2 Therefore, good collaboration between the treating physician and dentist is essential, to optimize dental and oral health prior to commencing antiresorptive treatment and to avoid dentoalveolar surgery during bone-targeted treatment.…”

Section: Discussionmentioning

confidence: 99%

Awareness of the risk of developing medication-related osteonecrosis of the jaw among bisphosphonate users

et al. 2020

View full text Add to dashboard Cite

Objective In this retrospective observational study, we evaluated awareness among patients using bisphosphonates (BPs) regarding the risk of developing medication-related osteonecrosis of the jaw (MRONJ) and whether they received appropriate dental screening and treatment prior to commencing medication. Methods Patients using BPs who attended the endodontics clinic at Jordan University Hospital in 2019 were interviewed using a pre-designed questionnaire. Data were analysed using descriptive statistics and chi-squared tests. Results In total, 110 patients were interviewed (84 women, 26 men; age 40–78 years). A total of 94 patients were using oral BP and 16 received intravenous (IV) BP. We found that only 12.4% of participants were aware about the risk of MRONJ following BP use, and only one third of them has received information from their prescribing physicians. In total, 5% of participants were referred to a dentist for screening prior to initiating BP treatment. Patients receiving IV BP and those with a university-level education had better awareness about the risk of MRONJ than oral BP users and those with a high school education level. Conclusion Patients’ awareness about MRONJ risk was low in our population. Better patient education and collaboration among physicians and dentists are needed prior to starting BP treatment.

show abstract

“…24 This study is a complementary study to previous studies performed on dentists. 25,26 It surveyed Iraqi general surgeons, urologists, orthopedic surgeons, rheumatologists, and oncologists to assess their knowledge about MRONJ in the form of questionnaires.…”

Section: Discussionmentioning

confidence: 99%

Perception of Medication-related Osteonecrosis of the Jaws among Iraqi Medical Specialists

Al-Samman¹,

Al-Ani

2020

European Dental Research and Biomaterials Journal

Self Cite

View full text Add to dashboard Cite

Objective Osteonecrosis of the jaws is the adverse effect of antiresorptive and antiangiogenic agents, which is termed as medication-related osteonecrosis of the jaws (MRONJ). This complication, which is prominent and growing, is seen in the oral and maxillofacial region. This cross-sectional survey aimed to evaluate MRONJ awareness among Iraqi medical specialists. Materials and Methods A questionnaire-based survey was performed on medical specialists practicing general surgery, urology, orthopedics, rheumatology, and oncology. The questionnaire consisted of four questions regarding drug prescription, patients’ preparation before drug administration, in addition to awareness and knowledge about MRONJ. Results Among 132 specialists, 57% did not prescribe such drugs. A significant difference existed among groups regarding dental referral, and MRONJ awareness and knowledge. The highest rates were seen in the oncologist group. Conclusions Improvement of MRONJ perception and knowledge among medical specialists, besides implementation of dental referral, are essential in the prevention, diagnosis and treatment of MRONJ.

show abstract

Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society

Cited by 8 publications

References 20 publications

Knowledge, attitude, and management of general dentist toward medication-related osteonecrosis of the jaws

Knowledge, attitude, and management of general dentist toward medication-related osteonecrosis of the jaws

Awareness of the risk of developing medication-related osteonecrosis of the jaw among bisphosphonate users

Perception of Medication-related Osteonecrosis of the Jaws among Iraqi Medical Specialists

Contact Info

Product

Resources

About